activated partial thromboplastin time
32 results
1 - 32
telavancin
nusinersen
olaratumab
bazedoxifene/conjugated estrogens
margetuximab
emicizumab
brigatinib
velaglucerase alfa
fruquintinib
ripretinib
tafasitamab
drotrecogin
aprotinin
factor ix (human)
anticoagulants
tivozanib
desirudin
argatroban
tisotumab vedotin
hetastarch
pembrolizumab
tirofiban
tenecteplase
avapritinib
desmopressin
thrombolytics
anistreplase
reteplase
urokinase
streptokinase
alteplase
piperacillin/tazobactam





